173 related articles for article (PubMed ID: 7491790)
1. Evidence that N-linked glycosylation is necessary for hepatitis B virus secretion.
Lu X; Mehta A; Dwek R; Butters T; Block T
Virology; 1995 Nov; 213(2):660-5. PubMed ID: 7491790
[TBL] [Abstract][Full Text] [Related]
2. Treatment of hepatitis B virus-infected cells with alpha-glucosidase inhibitors results in production of virions with altered molecular composition and infectivity.
Lazar C; Durantel D; Macovei A; Zitzmann N; Zoulim F; Dwek RA; Branza-Nichita N
Antiviral Res; 2007 Oct; 76(1):30-7. PubMed ID: 17548120
[TBL] [Abstract][Full Text] [Related]
3. N-linked glycosylation of hepatitis B surface antigens is involved but not essential in the assembly of hepatitis delta virus.
Wang CJ; Sung SY; Chen DS; Chen PJ
Virology; 1996 Jun; 220(1):28-36. PubMed ID: 8659125
[TBL] [Abstract][Full Text] [Related]
4. A C-terminal PreS1 sequence is sufficient to retain hepatitis B virus L protein in 293 cells.
Gallina A; Gazina E; Milanesi G
Virology; 1995 Oct; 213(1):57-69. PubMed ID: 7483279
[TBL] [Abstract][Full Text] [Related]
5. Osthole increases glycosylation of hepatitis B surface antigen and suppresses the secretion of hepatitis B virus in vitro.
Huang RL; Chen CC; Huang YL; Hsieh DJ; Hu CP; Chen CF; Chang C
Hepatology; 1996 Sep; 24(3):508-15. PubMed ID: 8781315
[TBL] [Abstract][Full Text] [Related]
6. Posttranslational N-glycosylation of the hepatitis B virus large envelope protein.
Lambert C; Prange R
Virol J; 2007 May; 4():45. PubMed ID: 17537250
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of host ER glucosidase activity prevents Golgi processing of virion-associated bovine viral diarrhea virus E2 glycoproteins and reduces infectivity of secreted virions.
Jordan R; Nikolaeva OV; Wang L; Conyers B; Mehta A; Dwek RA; Block TM
Virology; 2002 Mar; 295(1):10-9. PubMed ID: 12033761
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the cytosolic domains of the hepatitis B virus envelope proteins for their function in viral particle assembly and infectivity.
Blanchet M; Sureau C
J Virol; 2006 Dec; 80(24):11935-45. PubMed ID: 17020942
[TBL] [Abstract][Full Text] [Related]
9. Biogenesis of the hepatitis B viral middle (M) surface protein in a human hepatoma cell line: demonstration of an alternative secretion pathway.
Sheu SY; Lo SJ
J Gen Virol; 1994 Nov; 75 ( Pt 11)():3031-9. PubMed ID: 7964612
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus MHBs antigen is selectively sensitive to glucosidase-mediated processing in the endoplasmic reticulum.
Lu X; Lu Y; Geschwindt R; Dwek RA; Block TM
DNA Cell Biol; 2001 Oct; 20(10):647-56. PubMed ID: 11749723
[TBL] [Abstract][Full Text] [Related]
11. A unique amino acid substitution, L215Q, in the hepatitis B virus small envelope protein of a genotype F isolate that inhibits secretion of hepatitis B virus subviral particles.
Araujo NM; Vianna CO; Soares CC; Gomes SA
Intervirology; 2008; 51(2):81-6. PubMed ID: 18434744
[TBL] [Abstract][Full Text] [Related]
12. Antiviral effects of glycosylation and glucose trimming inhibitors on human parainfluenza virus type 3.
Tanaka Y; Kato J; Kohara M; Galinski MS
Antiviral Res; 2006 Oct; 72(1):1-9. PubMed ID: 16730076
[TBL] [Abstract][Full Text] [Related]
13. Both pre-S1 and S domains of hepatitis B virus envelope proteins interact with the core particle.
Poisson F; Severac A; Hourioux C; Goudeau A; Roingeard P
Virology; 1997 Feb; 228(1):115-20. PubMed ID: 9024817
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus (HBV) envelope glycoproteins vary drastically in their sensitivity to glycan processing: evidence that alteration of a single N-linked glycosylation site can regulate HBV secretion.
Mehta A; Lu X; Block TM; Blumberg BS; Dwek RA
Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1822-7. PubMed ID: 9050863
[TBL] [Abstract][Full Text] [Related]
15. Modification of the hepatitis B virus envelope protein glycosylation pattern interferes with secretion of viral particles, infectivity, and susceptibility to neutralizing antibodies.
Julithe R; Abou-Jaoudé G; Sureau C
J Virol; 2014 Aug; 88(16):9049-59. PubMed ID: 24899172
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of hepatitis B virus DNA replication by imino sugars without the inhibition of the DNA polymerase: therapeutic implications.
Mehta A; Carrouée S; Conyers B; Jordan R; Butters T; Dwek RA; Block TM
Hepatology; 2001 Jun; 33(6):1488-95. PubMed ID: 11391538
[TBL] [Abstract][Full Text] [Related]
17. A dominant hepatitis B virus population defective in virus secretion because of several S-gene mutations from a patient with fulminant hepatitis.
Kalinina T; Riu A; Fischer L; Will H; Sterneck M
Hepatology; 2001 Aug; 34(2):385-94. PubMed ID: 11481624
[TBL] [Abstract][Full Text] [Related]
18. Myristylation of the large surface protein is required for hepatitis B virus in vitro infectivity.
Bruss V; Hagelstein J; Gerhardt E; Galle PR
Virology; 1996 Apr; 218(2):396-9. PubMed ID: 8610467
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of a structural protein of hepatitis B virus: a polymerase and surface fusion protein encoded by a spliced RNA.
Huang HL; Jeng KS; Hu CP; Tsai CH; Lo SJ; Chang C
Virology; 2000 Sep; 275(2):398-410. PubMed ID: 10998339
[TBL] [Abstract][Full Text] [Related]
20. Effect of mutations in the small envelope protein of hepatitis B virus on assembly and secretion of hepatitis delta virus.
Jenna S; Sureau C
Virology; 1998 Nov; 251(1):176-86. PubMed ID: 9813213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
